Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
Achieve Centre for Applied Research, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, The Netherlands.
Heart. 2020 Jul;106(14):1066-1072. doi: 10.1136/heartjnl-2019-316056. Epub 2020 Mar 16.
To compare the treatment effect on lifestyle-related risk factors (LRFs) in older (≥65 years) versus younger (<65 years) patients with coronary artery disease (CAD) in The Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists 2 (RESPONSE-2) trial.
The RESPONSE-2 trial was a community-based lifestyle intervention trial (n=824) comparing nurse-coordinated referral with a comprehensive set of three lifestyle interventions (physical activity, weight reduction and/or smoking cessation) to usual care. In the current analysis, our primary outcome was the proportion of patients with improvement at 12 months follow-up (n=711) in ≥1 LRF stratified by age.
At baseline, older patients (n=245, mean age 69.2±3.9 years) had more adverse cardiovascular risk profiles and comorbidities than younger patients (n=579, mean age 53.7±6.6 years). There was no significant variation on the treatment effect according to age (p value treatment by age=0.45, OR 1.67, 95% CI 1.22 to 2.31). However, older patients were more likely to achieve ≥5% weight loss (OR old 5.58, 95% CI 2.77 to 11.26 vs OR young 1.57, 95% CI 0.98 to 2.49, p=0.003) and younger patients were more likely to show non-improved LRFs (OR old 0.38, 95% CI 0.22 to 0.67 vs OR young 0.88, 95% CI 0.61 to 1.26, p=0.01).
Despite more adverse cardiovascular risk profiles and comorbidities among older patients, nurse-coordinated referral to a community-based lifestyle intervention was at least as successful in improving LRFs in older as in younger patients. Higher age alone should not be a reason to withhold lifestyle interventions in patients with CAD.
比较老年(≥65 岁)与年轻(<65 岁)冠心病患者在门诊护士专科医生 2 随机评估二级预防试验(RESPONSE-2)中生活方式相关危险因素(LRFs)治疗效果。
RESPONSE-2 试验是一项基于社区的生活方式干预试验(n=824),比较了护士协调转诊与综合的三种生活方式干预(体力活动、减重和/或戒烟)与常规护理的效果。在当前分析中,我们的主要结局是在 12 个月随访时(n=711)≥1 LRF 改善的患者比例,按年龄分层。
在基线时,老年患者(n=245,平均年龄 69.2±3.9 岁)的心血管不良风险特征和合并症比年轻患者(n=579,平均年龄 53.7±6.6 岁)更多。根据年龄,治疗效果没有显著差异(p 值治疗与年龄=0.45,OR 1.67,95%CI 1.22 至 2.31)。然而,老年患者更有可能实现≥5%的体重减轻(OR 老 5.58,95%CI 2.77 至 11.26 与 OR 年轻 1.57,95%CI 0.98 至 2.49,p=0.003),而年轻患者更有可能出现 LRF 无改善(OR 老 0.38,95%CI 0.22 至 0.67 与 OR 年轻 0.88,95%CI 0.61 至 1.26,p=0.01)。
尽管老年患者的心血管不良风险特征和合并症更多,但以护士协调转诊至基于社区的生活方式干预,对改善老年患者的 LRFs 至少与年轻患者一样成功。年龄本身不应成为拒绝为 CAD 患者进行生活方式干预的理由。